News

Ketamine was not superior to morphine in reducing pain scores.

Data show lower incidence of CV events following intensive treatment with a systolic blood pressure target of 110 to 130 mm Hg compared to standard treatment.

Data show oral anticoagulation following atrial fibrillation screening was initiated in 1036 participants, with 445 (29.7%) in the ILR group versus 591 (13.1%) in the control group.

Fluoroquinolones use within 14 days of transplantation was 1 of the strongest risk factors for C difficile infections.

Dr. Bhatt discusses the growing field of knowledge surrounding icosapent ethyl treatment in cardiovascular care.

Despite conflicting evidence surrounding older patient populations, investigators found no age-specific treatment effects on major cardiovascular outcomes.

Recent phase 3 trial data confirms that dupilumab is the first biologic medicine is the first to reduce severity and symptoms of atopic dermatitis in pediatric patients.

Dr. Bhatt discusses a subgroup analysis of the REDUCE-IT to determine if icosapent ethyl reduced further ischemic events in patients with prior MI.

Investigators find that substitute salt better protects older people with a history of stroke or high blood pressure against secondary outcomes of cardiovascular events and death.

Incidence of death from cardiovascular causes was lower in the finerenone group (458 of 3686 patients) compared to the placebo group (519 of 3666 patients).

Net adverse clinical events occurred in 165 patients in the abbreviated-therapy group and 172 in the standard therapy group in patients at high bleeding risk after PCI.

The direct-acting oral anticoagulant benefitted prevention of adverse clinical events, but was associated with worse major bleeding.

New EMPEROR-Preserved findings show the SGLT-2 inhibitor significantly reduced heart failure-related hospitalizations, regardless of patient diabetes status.

Investigators argue that outdated practice laws and other methods hinder physician assistants and nurse practitioners from providing the best patient care and utilizing their skills during the COVID-19 pandemic.

A lack of PPE and high patient volumes were the leading causes of distress for nurses.

The vagus nerve stimulation system is the first of its kind stroke rehabilitation system, after supporting data from the VNS-REHAB trial suggested its efficacy in improving FMA-UE scores.

Depression is the leading cause of disability in the US.

The authors of a recent review recommend continued research on “powerful” new treatment methods that are effective in treating atopic diseases such as atopic eczema.

Investigators believe their study shows the efficacy and safety of the 2 biologic agents, which are known to have anti-inflammatory and immunosuppressant qualities.

There were 4 errors found involving wrong medications or injections in the wrong eye at KPNC in 2019 and 2020.

Investigators have found a negative association between the COPD and proton pump inhibitors through a familiar sequence symmetry analysis approach used to find associations between COPD and gastro-esophageal reflux disease.

Risk for major bleeding was found to be higher in patients treated with aspirin, ticagrelor compared to aspirin alone.

The new SLE test enhances specificity without sacrificing sensitivity.

Though operating room-based injections are predominantly performed, investigators could not find sufficient data that confirmed it as the only safe injection site.

New research shows 9 SNPs of 4 genes were significantly associated with the anti-VEGF therapy response in patients with age-related macular degeneration.

The new growth hormone has a weekly injection rate, as opposed to the daily injection rates of other growth hormones such as somatropin.

The investigative team in Canada found that pre-pregnancy weight may possibly influence a child’s risk of developing pediatric allergic diseases.

Clindamycin, fluoroquinolones, and ceftriaxone are associated with the highest risk of CDI.